Effects of chronic administration of drugs which modify neurotransmitter re-uptake, storage and turnover on levels of tyrosine and tryptophan hydroxylase in rat brain.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D003913:Dextroamphetamine / Q000494:pharmacology; D004327:Drinking Behavior / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D007099:Imipramine / Q000494:pharmacology; D007488:Iprindole / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000096:biosynthesis; D009435:Synaptic Transmission / Q000187:drug effects*; D013997:Time Factors; D014191:Tranylcypromine / Q000494:pharmacology; D014316:Tritium; D014365:Tryptophan Hydroxylase / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D014316:Tritium; D012701:Serotonin; D014191:Tranylcypromine; D007488:Iprindole; D012110:Reserpine; D010293:Pargyline; D006899:Mixed Function Oxygenases; D014446:Tyrosine 3-Monooxygenase; D014365:Tryptophan Hydroxylase; D007099:Imipramine; D003913:Dextroamphetamine